Skip to Content
 

News: December, 2016

A Helping Hand

Tuesday, December 6th, 2016

Imagine trying to navigate an unfamiliar Medical Center with appointments sprinkled across numerous buildings, often on different days of the week. Now add a cancer diagnosis, and the emotions that come with that, and traversing unfamiliar surroundings becomes infinitely more difficult. Your life has just been turned upside down and there’s much to do. There […]

A commitment to better care

Tuesday, December 6th, 2016

The five-year CMS Oncology Care Model will provide treatment following nationally recognized clinical guidelines for patients undergoing chemotherapy, with an emphasis on patient-centered care delivered in a timely, coordinated manner. The services may include: Coordinating appointments with providers within and outside the oncology practice to ensure timely delivery of diagnostic and treatment services; Providing 24/7 […]

Lisa Kachnic ushers in a new era for radiation oncology

Tuesday, December 6th, 2016

One year into her job as chair of Radiation Oncology, Lisa Kachnic, M.D., is leading Vanderbilt-Ingram Cancer Center into a new era for a century-old therapy. Radiotherapy continues to be at the forefront of cancer research as doctors devise better ways to target tumors and understand how radiation interacts with some of the new immunotherapies. […]

Not the End of the World

Tuesday, December 6th, 2016

El Camino de Santiago is a collection of routes throughout Europe that pilgrims have been walking for centuries. All the trails lead to the 800-year-old cathedral in Santiago de Compostela, Spain, which holds the remains of the apostle, Saint James. In 2012, I completed the first 200 miles of El Camino de Santiago’s 500-mile French […]

Journal Watch

Tuesday, December 6th, 2016

VUMC study: current cancer drug discovery method flawed The primary method used to test compounds for anti-cancer activity in cells is flawed, Vito Quaranta, M.D., and colleagues reported May 2 in Nature Methods. The scientists developed a new metric to evaluate a compound’s effect on cell proliferation. The old system counted how many cancer cells […]

News Around the Cancer Center

Tuesday, December 6th, 2016

Hiebert appointed to national cancer board Scott Hiebert, Ph.D., professor of Biochemistry and associate professor of Medicine, has been appointed to the National Cancer Advisory Board (NCAB). The NCAB consists of 18 members appointed by the President to advise the director of the National Cancer Institute (NCI), a division of the National Institutes of Health […]

« Previous Page